123 related articles for article (PubMed ID: 6609159)
1. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
Pan LC; Price PA
J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
[TBL] [Abstract][Full Text] [Related]
2. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
Theofan G; Price PA
Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines.
Fraser JD; Otawara Y; Price PA
J Biol Chem; 1988 Jan; 263(2):911-6. PubMed ID: 3257212
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
5. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.
Fraser JD; Price PA
Calcif Tissue Int; 1990 Apr; 46(4):270-9. PubMed ID: 2108798
[TBL] [Abstract][Full Text] [Related]
6. The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats.
Wientroub S; Price PA; Reddi AH
Calcif Tissue Int; 1987 Mar; 40(3):166-72. PubMed ID: 3105848
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood BD
Endocrinology; 1990 Aug; 127(2):588-94. PubMed ID: 2115429
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of calcium-regulating hormones on the synthesis and/or secretion of bone gamma-carboxyglutamic acid-containing protein in chick embryonic calvaria in vitro.
Tsutsumi C; Hoshiba K; Moriuchi S; Orimo H; Hosoya N
J Nutr Sci Vitaminol (Tokyo); 1986 Apr; 32(2):157-69. PubMed ID: 3020205
[TBL] [Abstract][Full Text] [Related]
9. In vivo effects of transcriptional and translational inhibitors on duodenal vitamin D-dependent calcium-binding protein messenger ribonucleic acid stimulation by 1,25-dihydroxycholecalciferol.
Dupret JM; Brun P; Thomasset M
Endocrinology; 1986 Dec; 119(6):2476-83. PubMed ID: 3780535
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3.
Mosavin R; Mellon WS
Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid protein synthesis by rat osteosarcoma cells.
Nishimoto SK; Salka C; Nimni ME
J Bone Miner Res; 1987 Dec; 2(6):571-7. PubMed ID: 3484302
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells.
Price PA; Baukol SA
J Biol Chem; 1980 Dec; 255(24):11660-3. PubMed ID: 6969260
[TBL] [Abstract][Full Text] [Related]
14. Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells.
Franceschi RT; Romano PR; Park KY
J Biol Chem; 1988 Dec; 263(35):18938-45. PubMed ID: 3264282
[TBL] [Abstract][Full Text] [Related]
15. Ongoing protein synthesis needed for 1,25-(OH)2D3-mediated rapid increase of cyclic GMP in human skin fibroblasts.
Barsony J; Marx SJ
FEBS Lett; 1988 Aug; 235(1-2):207-10. PubMed ID: 2456949
[TBL] [Abstract][Full Text] [Related]
16. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
17. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
[TBL] [Abstract][Full Text] [Related]
18. Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription.
Demay MB; Roth DA; Kronenberg HM
J Biol Chem; 1989 Feb; 264(4):2279-82. PubMed ID: 2783691
[TBL] [Abstract][Full Text] [Related]
19. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
20. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
